Mymetics receives HIV Vaccine Funding from the NIH

Author's Avatar
Apr 29, 2019
Article's Main Image

- Funding to prepare Mymetics' cold chain independent needle free mucosal virosome HIV vaccine candidate for clinical trials

- Collaboration with Texas Biomedical Research Institute and University of Louisiana at Lafayette

- Total award USD 8.5 million over 5 years, with USD 1.9 million budget in the first year

PR Newswire